Project profile — Gavi Alliance - Institutional Support - 2016-2020



Overview 

CA-3-D002243001
$500,000,000
Gavi, The Vaccine Alliance (47122)
2015-09-17 - 2021-12-31
Operational
Global Affairs Canada
MFM Global Issues & Dev.Branch

Country / region 

• Africa, regional (71.80%)
• America, regional (5.60%)
• Asia, regional (22.60%)

Sector 

• Basic Health: Infectious disease control (12250) (100.00%)

Policy marker 

• Gender equality (significant objective)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• ICT as a tool for development (not targeted)

Description 

Canada’s support to Gavi, the Vaccine Alliance will assist in the realisation of Gavi’s Strategic Plan for 2016-2020, which aims to save 5-6 million children’s lives through equitable use of vaccines in lower income countries. Approximately 80% of these funds will be provided to procure and deliver vaccines requested by countries for their national immunizations programs. The remaining 20% of funds will be provided to countries to strengthen national health systems, including increasing health worker capacity and training and strengthening of supply and cold chain systems to support immunization programs. Gavi is a global health partnership created to address global inequities in access to new and underused vaccines.

Expected results 

The expected results for this project include: (1) accelerated equitable uptake and coverage of vaccines (2) increased effectiveness and efficiency of immunization delivery as an integrated part of strengthened health systems; (3) improved sustainability of national immunization programs; and (4) improved markets for vaccines and other immunization products.

Results achieved 

N/A

Budget and spending 


Original budget $0
Planned disbursement $0
Transactions
Country percentages by sector
Type of finance Aid grant excluding debt reorganisation
Collaboration type Multilateral
Type of aid Core contributions to multilateral institutions
Date modified: